Cannabidiol Attenuates Cardiac Dysfunction, Oxidative Stress, Fibrosis, and Inflammatory and Cell Death Signaling Pathways in Diabetic Cardiomyopathy

Fein, 1990, Diabetic cardiomyopathy, Diabetes Care, 13, 1169, 10.2337/diacare.13.11.1169

Regan, 1994, Diabetic cardiomyopathy: experimental and clinical observations, N J Med, 91, 776

Asbun, 2006, The pathogenesis of myocardial fibrosis in the setting of diabetic cardiomyopathy, J Am Coll Cardiol, 47, 693, 10.1016/j.jacc.2005.09.050

Kajstura, 2001, IGF-1 overexpression inhibits the development of diabetic cardiomyopathy and angiotensin II-mediated oxidative stress, Diabetes, 50, 1414, 10.2337/diabetes.50.6.1414

Pacher, 2007, Nitric oxide and peroxynitrite in health and disease, Physiol Rev, 87, 315, 10.1152/physrev.00029.2006

Cai, 2006, Attenuation by metallothionein of early cardiac cell death via suppression of mitochondrial oxidative stress results in a prevention of diabetic cardiomyopathy, J Am Coll Cardiol, 48, 1688, 10.1016/j.jacc.2006.07.022

Wang, 2009, Inactivation of GSK-3beta by metallothionein prevents diabetes-related changes in cardiac energy metabolism, inflammation, nitrosative damage, and remodeling, Diabetes, 58, 1391, 10.2337/db08-1697

Aragno, 2006, Oxidative stress-dependent impairment of cardiac-specific transcription factors in experimental diabetes, Endocrinology, 147, 5967, 10.1210/en.2006-0728

Mariappan, 2010, NF-kappaB-induced oxidative stress contributes to mitochondrial and cardiac dysfunction in type II diabetes, Cardiovasc Res, 85, 473, 10.1093/cvr/cvp305

Pacher, 2002, The role of poly(ADP-ribose) polymerase activation in the development of myocardial and endothelial dysfunction in diabetes, Diabetes, 51, 514, 10.2337/diabetes.51.2.514

Westermann, 2006, Inhibition of p38 mitogen-activated protein kinase attenuates left ventricular dysfunction by mediating pro-inflammatory cardiac cytokine levels in a mouse model of diabetes mellitus, Diabetologia, 49, 2507, 10.1007/s00125-006-0385-2

Thandavarayan, 2009, Dominant-negative p38{alpha} mitogen-activated protein kinase prevents cardiac apoptosis and remodeling after streptozotocin-induced diabetes mellitus, Am J Physiol Heart Circ Physiol, 297, H911, 10.1152/ajpheart.00124.2009

Van Linthout, 2008, Human apolipoprotein a-I gene transfer reduces the development of experimental diabetic cardiomyopathy, Circulation, 117, 1563, 10.1161/CIRCULATIONAHA.107.710830

Frustaci, 2000, Myocardial cell death in human diabetes, Circ Res, 87, 1123, 10.1161/01.RES.87.12.1123

Westermann, 2007, Contributions of inflammation and cardiac matrix metalloproteinase activity to cardiac failure in diabetic cardiomyopathy: the role of angiotensin type 1 receptor antagonism, Diabetes, 56, 641, 10.2337/db06-1163

Pacher, 2006, The endocannabinoid system as an emerging target of pharmacotherapy, Pharmacol Rev, 58, 389, 10.1124/pr.58.3.2

Pacher, 2009, The emerging role of the endocannabinoid system in cardiovascular disease, Semin Immunopathol, 31, 63, 10.1007/s00281-009-0145-8

Barnes, 2006, Sativex: clinical efficacy and tolerability in the treatment of symptoms of multiple sclerosis and neuropathic pain, Expert Opin Pharmacother, 7, 607, 10.1517/14656566.7.5.607

Thomas, 1998, Comparative receptor binding analyses of cannabinoid agonists and antagonists, J Pharmacol Exp Ther, 285, 285

Izzo, 2009, Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb, Trends Pharmacol Sci, 30, 515, 10.1016/j.tips.2009.07.006

Cunha, 1980, Chronic administration of cannabidiol to healthy volunteers and epileptic patients, Pharmacology, 21, 175, 10.1159/000137430

Consroe, 1991, Controlled clinical trial of cannabidiol in Huntington's disease, Pharmacol Biochem Behav, 40, 701, 10.1016/0091-3057(91)90386-G

Durst, 2007, Cannabidiol, a nonpsychoactive Cannabis constituent, protects against myocardial ischemic reperfusion injury, Am J Physiol Heart Circ Physiol, 293, H3602, 10.1152/ajpheart.00098.2007

Gaoni, 1971, The isolation and structure of delta-1-tetrahydrocannabinol and other neutral cannabinoids from hashish, J Am Chem Soc, 93, 217, 10.1021/ja00730a036

Mukhopadhyay, 2007, Pharmacological inhibition of CB1 cannabinoid receptor protects against doxorubicin-induced cardiotoxicity, J Am Coll Cardiol, 50, 528, 10.1016/j.jacc.2007.03.057

Pacher, 2008, Measurement of cardiac function using pressure-volume conductance catheter technique in mice and rats, Nat Protocols, 3, 1422, 10.1038/nprot.2008.138

Mukhopadhyay, 2007, Simultaneous detection of apoptosis and mitochondrial superoxide production in live cells by flow cytometry and confocal microscopy, Nat Protocols, 2, 2295, 10.1038/nprot.2007.327

Weiss, 2008, Cannabidiol arrests onset of autoimmune diabetes in NOD mice, Neuropharmacology, 54, 244, 10.1016/j.neuropharm.2007.06.029

El-Remessy, 2006, Neuroprotective and blood-retinal barrier-preserving effects of cannabidiol in experimental diabetes, Am J Pathol, 168, 235, 10.2353/ajpath.2006.050500

Westermann, 2007, Tumor necrosis factor-alpha antagonism protects from myocardial inflammation and fibrosis in experimental diabetic cardiomyopathy, Basic Res Cardiol, 102, 500, 10.1007/s00395-007-0673-0

Hampson, 1998, Cannabidiol and (-)delta9-tetrahydrocannabinol are neuroprotective antioxidants, Proc Natl Acad Sci USA, 95, 8268, 10.1073/pnas.95.14.8268

Malfait, 2000, The nonpsychoactive cannabis constituent cannabidiol is an oral anti-arthritic therapeutic in murine collagen-induced arthritis, Proc Natl Acad Sci USA, 97, 9561, 10.1073/pnas.160105897

Kozela, 2010, Cannabinoids delta(9)-tetrahydrocannabinol and cannabidiol differentially inhibit the lipopolysaccharide-activated NF-kappaB and interferon-beta/STAT proinflammatory pathways in BV-2 microglial cells, J Biol Chem, 285, 1616, 10.1074/jbc.M109.069294